CEMIPLIMAB-RWLC vs DOSTARLIMAB

# EARNINGS Helen of Troy (HELE) Q2 Adj. EPS USD 1.98 vs. Exp. USD 1.60, revenue USD 393.55mln vs. Exp. USD 349.19mln; raises FY19 Adj. EPS USD 7.65-7.90 vs. Exp. USD 7.62. (Newswires) #DJIA Apple (AAPL) – The behemoth’s 2018 iPad Pro models are to include edge-to-edge displays, Face ID, USB

Just want to re-iterate. I'm not a prophet. Not a teacher. I don't speak in front of live audiences. I have zero out of body experiences. No dreams. It's just me here. I'm like you, studying it. Everything I say is how I interpret it. If you're reading this, then, it's up to you to balance,

Here is another long look at the past couple of years. Take it as you may. This is a discussion, not a declaration of truth. This is an interpretation of what we know via statement and a hypothetical assembly of those words into what may be behind them. Let's try to put it together the way it cou

I copied here for convenience, the PR of 11/22/22: # "CytoDyn to Host R&D Update on Wednesday, December 7, 2022 VANCOUVER, Washington, Nov. 22, 2022 (GLOBE NEWSWIRE) -- **CytoDyn Inc. (OTCQB: CYDY)** ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist w

I know I put out a post yesterday, but for the sake of consistency, I did not want a Sunday to pass without a signature post. I'm not yet ready to break that trend. So here you go. But, I am pleased to see more and more posters. In [last week's post](https://www.reddit.com/r/Livimmune/comments/1g

I’m starting carboplatin/paclitaxel and dostarlimab for endometrial cancer on Feb 18th. It will be 6 infusions every three weeks with the immunotherapy continuing every 6 weeks for 3 years if all goes as planned. My oncologist stated that most of her patients continue to work through chemo. I’m a fi

Hi Guys, I am Jon 39 from Germany. I was diagnosed with Lynch syndrome with an advanced rectal tumor at the age of 21. Cancer has been with my family for generations; my grandfather died of colon cancer at the age of 36 and my mother died at the age of 57. Since my diagnosis in 2007 and neoadjuvant

The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s National Priority Voucher,” a ticket to speedier reviews of drug candidates aligned with U.S. priorities. The announcement came as the Trump administration unveiled agreements with E

# Pipeline Development Acrivon Therapeutics specializes in oncology through its Acrivon Predictive Precision Proteomics (AP3) platform, which identifies compound-specific protein signatures to predict patient response. While the company positions AP3 as a repeatable discovery engine, it currently re